| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/03/2014 | US8741329 Drug delivery system |
| 06/03/2014 | US8741326 Modified two-component gelation systems, methods of use and methods of manufacture |
| 06/03/2014 | US8741319 Methods and compositions for treating anxiety disorders or symptoms thereof |
| 06/03/2014 | US8741318 Multicomponent and biocompatible nanocomposite materials, methods of synthesizing same and applications of same |
| 06/03/2014 | US8741317 Slow-degrading polymers comprising salicylic acid for undelayed and sustained drug delivery |
| 06/03/2014 | US8741316 Highly porous, recognitive polymer systems |
| 06/03/2014 | US8741303 Immunogenic LHRH compositions and methods relating thereto |
| 06/03/2014 | US8741265 Penetrating pharmaceutical foam |
| 06/03/2014 | US8741192 Method and device for producing micro-droplets |
| 06/03/2014 | US8741051 Coating composition comprising polydextrose, process for preparing same and use of coating ingestible solid forms |
| 06/03/2014 | US8740879 Instrumented orthopedic and other medical implants |
| 06/03/2014 | CA2799437C Method of producing hydroxyalkyl starch derivatives |
| 06/03/2014 | CA2671081C Stabilized adhesive preparation containing donepezil |
| 06/03/2014 | CA2649538C Buffering agents for biopharmaceutical formulations |
| 06/03/2014 | CA2649207C Magnetic nanoparticles compositions and uses thereof |
| 06/03/2014 | CA2648854C Fluid container and airless fluid dispensing system |
| 06/03/2014 | CA2633356C Pharmaceutical composition containing donepezil hydrochloride, tablets produced therefrom and method for producing the same |
| 06/03/2014 | CA2630099C Self-assembling monomers and oligomers as surface-modifying endgroups for polymers |
| 06/03/2014 | CA2595496C Medicament that is intended for oral administration, comprising a cyclooxygenase-2 inhibitor, and preparation method thereof |
| 06/03/2014 | CA2578225C Testosterone gels comprising propylene glycol as penetration enhancer |
| 06/03/2014 | CA2565296C Sustained-release microspheres and methods of making and using same |
| 06/03/2014 | CA2432523C Compositions of stable t3 and methods of use thereof |
| 06/03/2014 | CA2395892C Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release |
| 06/02/2014 | DE202012012985U1 Medizinische Anwendung zur Therapie lokaler Symptome Medical application for the treatment of localized symptoms |
| 05/30/2014 | WO2014081887A1 Improved method for the preparation of liposome encapsulated vincristine for therapeutic use |
| 05/30/2014 | WO2014081849A1 Formulations of active agents for sustained release |
| 05/30/2014 | WO2014081674A1 Topical dapsone and dapsone/adapalene compositions and methods for use thereof |
| 05/30/2014 | WO2014081443A1 Caspofungin acetate formulations |
| 05/30/2014 | WO2014081392A1 Composition and method for respiratory delivery of dye for visualisation of eye |
| 05/30/2014 | WO2014081340A1 Inhalation composition in the form of an aerosol for the treatment of bronchial asthma and chronic obstructive pulmonary disease |
| 05/30/2014 | WO2014081338A1 Medicinal agent in the form of an orodispersible tablet and method for producing same |
| 05/30/2014 | WO2014081220A1 Amylase-activity-inhibiting composition containing chito-oligosaccharide |
| 05/30/2014 | WO2014081172A1 Effervescent super-disintegrating imatinib preparation and production method for same |
| 05/30/2014 | WO2014080954A1 Adhesive composition for skin, adhesive for skin, and adhesive sheet for skin |
| 05/30/2014 | WO2014080784A1 Aqueous olanzapine pharmaceutical preparation of having longterm stability |
| 05/30/2014 | WO2014080384A1 Pharmaceutical composition of linagliptin |
| 05/30/2014 | WO2014080383A1 Pharmaceutical composition of dipeptidyl peptidase-iv (dpp-iv) inhibitors in combination with other antidiabetics |
| 05/30/2014 | WO2014080365A1 Method of reducing an unpleasant odor of a pharmaceutical composition |
| 05/30/2014 | WO2014080285A2 Pharmaceutical compositions having improved storage stability |
| 05/30/2014 | WO2014080035A1 Micronizer |
| 05/30/2014 | WO2014079922A1 Composition for immediate and extended release |
| 05/30/2014 | WO2014079890A1 Titanate nanostructure for regenerating and engineering tissue |
| 05/30/2014 | WO2014079825A1 Manufacturing of semi-plastic pharmaceutical dosage units |
| 05/30/2014 | WO2014079801A1 Method for increasing the particle size of crystalline active micro-particles |
| 05/30/2014 | WO2014079573A1 Multi-day patch for the transdermal administration of rotigotine |
| 05/30/2014 | WO2014079151A1 Use of statin compound in preparation of topical drug for treating obesity, diabetes, hypertension and hyperlipaemia |
| 05/30/2014 | WO2014057432A9 Multicomponent lipid nanoparticles and processes for the preparation thereof |
| 05/30/2014 | WO2014054005A3 Nanosomal preparation of the complex formed by quercetin (or another flavonol, flavone or a derivative thereof) and 2-hydroxypropyl-β-cyclodextrin for intravenous use in cerebral pathological conditions |
| 05/30/2014 | WO2014053822A4 Layered double hydroxides |
| 05/30/2014 | WO2014053328A3 Pharmaceutical compositions |
| 05/30/2014 | WO2014041378A3 Topical pharmaceutical composition comprising tenofovir, an antibacterial agent and,optonally ciclopirox |
| 05/30/2014 | WO2014033751A3 Pharmaceutical composition of propofol |
| 05/30/2014 | WO2014031491A3 Production of nitric oxide from microencapsulated reactants |
| 05/30/2014 | WO2014027975A3 Novel orally administered pharmaceutical formulations |
| 05/30/2014 | WO2013037479A8 Ophthalmic compositions comprising prostaglandin f2 alpha derivatives and hyaluronic acid |
| 05/29/2014 | US20140148900 Device and method for intraocular drug delivery |
| 05/29/2014 | US20140148509 Stabilized ascorbic acid solutions; method of use thereof; process for their obtention; and compositions comprising the same |
| 05/29/2014 | US20140148507 Pharmaceutical composition and solid galenic form having a high dronedarone content, and method for preparing same |
| 05/29/2014 | US20140148506 Drug elating silicone gel sheeting for wound healing and scar reduction |
| 05/29/2014 | US20140148495 Monolithic drug delivery system |
| 05/29/2014 | US20140148491 Chemical Compositions And Methods For Enhancing Transdermal Delivery Of Therapeutic Agents |
| 05/29/2014 | US20140148490 Bendamustine pharmaceutical compositions |
| 05/29/2014 | US20140148486 Sodium channel blocker delivery system with scleral lens |
| 05/29/2014 | US20140148426 Use of a Clobetasol Spray Formulation to Treat Psoriasis |
| 05/29/2014 | US20140147517 Use of Amisulpride as an Anti-Emetic |
| 05/29/2014 | US20140147511 Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof |
| 05/29/2014 | US20140147510 Multiphasic polymeric particles capable of shape-shifting via environmental stimulation |
| 05/29/2014 | US20140147509 Microorganism comprising particles and uses of same |
| 05/29/2014 | US20140147508 Nano-Carrier, Complex of Anticancer Drug and Nano-Carrier, Pharmaceutical Composition Thereof, Method for Manufacturing the Complex, and Method for Treating Cancer by Using the Pharmaceutical Composition |
| 05/29/2014 | US20140147506 Delivery of Submicrometer and Nanometer Aerosols to the Lungs using Hygroscopic Excipients or Dual Stream Nasal Delivery |
| 05/29/2014 | US20140147505 Solid pharmaceutical dosage form of ticagrelor |
| 05/29/2014 | US20140147501 Method for the embedding and encapsulation of components |
| 05/29/2014 | US20140147500 Preparation and Use of Combination Enzyme and Gastrointestinal Modulator Delivery Systems |
| 05/29/2014 | US20140147499 Abuse-proofed oral dosage form |
| 05/29/2014 | US20140147498 Compositions containing coenzyme q-10 and dihydrolipoic acid |
| 05/29/2014 | US20140147497 Pediatric formulation |
| 05/29/2014 | US20140147494 Delivery Substrates From Aligned Polymer Biomaterials For Tissue Repair |
| 05/29/2014 | US20140147493 Pcr-based gene delivery carrier and method for preparing the same |
| 05/29/2014 | US20140147491 Treatment of autism spectrum disorders using glycyl-l-2-methylprolyl-l-glutamic acid |
| 05/29/2014 | US20140147489 Rapidly dissolving film for delivery of an active agent |
| 05/29/2014 | US20140147488 Feed or food product composition |
| 05/29/2014 | US20140147487 Methods of Using Water-Soluble Inorganic Compounds for Implants |
| 05/29/2014 | US20140147486 Implants for the treatment of dopamine associated states |
| 05/29/2014 | US20140147484 Cell-Free Tissue Engineered Vascular Grafts |
| 05/29/2014 | US20140147482 Artificial tissue constructs comprising alveolar cells and methods for using the same |
| 05/29/2014 | US20140147481 Anti-inflammatory and quorum sensing inhibition compounds and methods of making and using them |
| 05/29/2014 | US20140147477 Prodrugs of (1s,9s)-9-[[(1s)-1-carboxy-3-phenylpropyl]amino]octahydro-10-oxo-6h-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid and their use in transdermal therapeutic systems |
| 05/29/2014 | US20140147476 Organic nanotube having hydrophobized inner surface, and encapsulated medicinal agent prepared using the nanotube |
| 05/29/2014 | US20140147474 Pharmaceutical emulsion compositions comprising progestogen |
| 05/29/2014 | US20140147449 Compositions and Methods for Treating Inflammatory Conditions of the Ocular Surface |
| 05/29/2014 | US20140147393 Pharmaceutical Composition |
| 05/29/2014 | US20140147389 Antigen Specific Ultrasound Contrast Medium, a Process for the Preparation Thereof and Its Uses |
| 05/29/2014 | US20140145000 Nebulizer, a control unit for controlling the same, and a method of controlling a nebulizer |
| 05/28/2014 | EP2735608A1 Core-shell composite having poly-vinylalcohol and alginate and method for fabricating the same |
| 05/28/2014 | EP2735315A1 Stable protein-containing preparation containing argininamide or analogous compound thereof |
| 05/28/2014 | EP2735314A1 Improved sugar-coated liposome composition |
| 05/28/2014 | EP2735308A1 Water-based plaster |
| 05/28/2014 | EP2735307A1 Compacted Moxifloxacin |
| 05/28/2014 | EP2735306A1 Method for manufacturing a pharmaceutical composition in the form of extended-release tablets containing pirfenidone and use thereof in the regression of chronic renal insufficiency, breast capsular contracture and hepatic fibrosis in humans |
| 05/28/2014 | EP2735305A1 Stabilised liquid pharmaceutical preparations |